|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn952337016 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160125s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020678064
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d YDXCP
|d N$T
|d OCLCF
|d SNK
|d DKU
|d AUW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d VLY
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781634847247
|q ebook
|
| 020 |
|
|
|a 1634847245
|
| 020 |
|
|
|z 163484713X
|
| 020 |
|
|
|z 9781634847131
|
| 029 |
1 |
|
|a AU@
|b 000060915841
|
| 035 |
|
|
|a (OCoLC)952337016
|
| 050 |
0 |
0 |
|a RC280.B48
|
| 060 |
|
4 |
|a WI 765
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/436
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Bile duct cancer :
|b symptoms, treatment, and prognosis /
|c Donna E. Matthews, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a cancer etiology, diagnosis and treatments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a BILE DUCT CANCER SYMPTOMS, TREATMENT AND PROGNOSIS ; BILE DUCT CANCER SYMPTOMS, TREATMENT AND PROGNOSIS ; CONTENTS ; PREFACE; Chapter 1 CHOLANGIOCARCINOMA: SYMPTOMS AND CURRENT STATE OF MEDICAL AND SURGICAL MANAGEMENT ; ABSTRACT; INTRODUCTION; SYMPTOMS ; TREATMENT; INTRAHEPATIC CHOLANGIOCARCINOMA ; HILAR CHOLANGIOCARCINOMA AND EXTRAHEPATIC CHOLANGIOCARCINOMA ; PROGNOSIS ; REFERENCES ; Chapter 2 EXTRA HEPATIC CHOLANGIOCARCINOMA: SYMPTOMS, TREATMENT AND PROGNOSIS ; ABSTRACT ; EPIDEMIOLOGY ; RISK FACTORS ; CLINICAL PRESENTATION ; DIAGNOSTIC WORK-UP ; ANATOMY
|
| 505 |
8 |
|
|a LABORATORY INVESTIGATIONS IMAGING ; Ultrasound (US) ; Computed Tomography (CT)/Multi-Detector Computed Tomography (MDCT) ; Magnetic Resonance Imaging (MRI) ; Endoscopic Retrograde Cholangiopancreatography (ERCP)/Percutaneous Transhepatic Cholangiography (PTC) ; Endoscopic Ultrasonography (EUS)/Intraductal Ultrasonography (IDUS) ; Positron Emission Tomography (PET) ; Biopsy ; Staging ; Treatment; Distal Cholangiocarcinoma ; Perihilar Cholangiocarcinoma ; Preoperative Liver Evaluation/Interventions ; TREATMENT OF BILIARY OBSTRUCTION ; Adjuvant Therapies
|
| 505 |
8 |
|
|a Neoadjuvant Therapy and Transplantation Palliative Treatment ; REFERENCES ; Chapter 3 PREVALENCE OF BILE DUCT CANCER AS MEASURED BY DISCHARGES FROM DIAGNOSIS-PROCEDURE-COMBINATION (DPC) PARTICIPATING HOSPITALS AMONG BENEFICIARIES OF A PRINTING INDUSTRY HEALTH INSURANCE SOCIETY IN COMPARISON WITH GENERAL POPULATION ; ABSTRACT ; INTRODUCTION ; SUBJECTS AND METHODS ; 1. DPC Data from General Population ; 2. DPC data from HISPI; 3. Analysis ; 4. Ethical Approval ; RESULTS ; DISCUSSION ; ACKNOWLEDGMENTS ; REFERENCES ; Chapter 4 MEDICAL TREATMENT OF ADVANCED BILIARY TRACT CANCER ; ABSTRACT
|
| 505 |
8 |
|
|a 1.1. INTRODUCTION 1.2. CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER ; 1.2.1. Combinations of Gemcitabine and Platinum Derivatives ; 1.2.2. Combinations of Gemcitabine and Fluoropyrimidines ; 1.2.3. Triple-Drug Chemotherapy Regimens; 1.2.4. S-1 Based Combinations ; 1.2.5. Second-Line Chemotherapy ; 1.3 TARGETED THERAPIES IN ADVANCED BILIARY DUCT CANCER ; 1.3.1. Therapies Targeting EGFR Pathway ; 1.3.1.1. Erlotinib; 1.3.1.2. Cetuximab ; 1.3.1.3. Panitumumab; 1.3.1.4. Afatinib ; 1.3.2. Therapies Targeting the VEGF Pathway ; 1.3.2.1. Bevacizumab ; 1.3.2.2. Sunitinib ; 1.3.2.3. Cediranib
|
| 505 |
8 |
|
|a 1.3.2.4. Sorafenib1.4. IMMUNOTHERAPY IN BILIARY TRACT CANCER ; 1.4.1. Tumor-Associated-Antigens ; 1.4.2. Checkpoint Inhibitors ; 1.4.3. How Can We Explain an Enhanced Immune Response in Biliary Cancers? ; CONCLUSION ; REFERENCES ; BIOGRAPHICAL SKETCH ; INDEX
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Bile ducts
|x Cancer.
|
| 650 |
|
2 |
|a Bile Duct Neoplasms
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Bile ducts
|x Cancer.
|2 fast
|0 (OCoLC)fst00831700
|
| 700 |
1 |
|
|a Matthews, Donna E.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Bile duct cancer
|d New York : Nova Biomedical, [2016]
|z 9781634847131
|w (DLC) 2016931579
|
| 830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1258682
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13048988
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1258682
|
| 994 |
|
|
|a 92
|b IZTAP
|
